Music Therapy for ICU Delirium
(DDM Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if listening to slow-tempo music can reduce delirium (a state of confusion) in older adults who are critically ill and on ventilators in the ICU. Participants will either listen to relaxing music or sit in silence for an hour, twice a day, over a week. The trial seeks to discover if music can increase the number of days patients remain free from delirium or coma. Suitable candidates are English-speaking individuals aged 50 or older, who are in the ICU, expected to need a ventilator for at least 48 hours, and have someone who can provide consent on their behalf. As an unphased trial, this study offers a unique opportunity to explore innovative non-drug therapies that could enhance patient well-being.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this music therapy is safe for ICU patients?
Research shows that slow-tempo music is safe for patients in intensive care. Studies have found that listening to music with a slow beat (60-80 beats per minute) can lower the risk of confusion in ICU patients. Patients tolerate this type of music well and experience fewer days of confusion or coma when they listen to it regularly.
A review of studies also found that slow-tempo music can reduce pain and improve sleep. Importantly, these studies report no negative effects from this music therapy. Therefore, for those considering joining a trial involving slow-tempo music, current research supports it as a safe and potentially helpful treatment.12345Why are researchers excited about this trial?
Unlike standard treatments for ICU delirium that often rely on medications to manage symptoms, slow tempo music offers a non-invasive alternative that aims to soothe and calm patients through auditory stimulation. This approach uses relaxing music at 60-80 beats per minute, delivered through noise-canceling headphones, which could potentially reduce stress and confusion without the side effects associated with drugs. Researchers are excited about this treatment because it harnesses the natural power of music to influence mood and cognitive function, offering a novel way to improve patient outcomes in a critical care environment.
What evidence suggests that slow tempo music might be an effective treatment for ICU delirium?
Research has shown that slow-tempo music, which participants in this trial may receive, can help reduce confusion and disorientation in very sick patients. Studies have found that listening to music can lower anxiety, stress, and the need for strong sedatives. Reducing these factors might mean patients spend less time in a confused state or coma. In some cases, music therapy has also been linked to shorter times on breathing machines for patients in intensive care. While more research is needed, these findings suggest that music could be a useful tool for those at risk of confusion in the ICU. Another group in this trial will receive attention control, consisting of silence sessions, to compare the effects.23678
Who Is on the Research Team?
Linda Chlan, PhD, RN
Principal Investigator
Mayo Clinic
Babar Khan, MD, MS
Principal Investigator
Indiana University
Are You a Good Fit for This Trial?
This trial is for critically ill adults over 50 in the ICU who are expected to need a ventilator for at least 48 hours and can consent through a representative. They must speak English, have phone access, and not have hearing/vision impairments, certain neurological conditions, uncontrolled psychiatric illness, or be at risk of alcohol/drug withdrawal.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a seven-day slow-tempo music intervention to evaluate its efficacy on delirium/coma free days
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessments of pain, cognition, depression, and anxiety
What Are the Treatments Tested in This Trial?
Interventions
- Attention Control
- Slow Tempo Music
Find a Clinic Near You
Who Is Running the Clinical Trial?
Indiana University
Lead Sponsor
National Institute on Aging (NIA)
Collaborator